Novo Nordisk’s US Public Affairs Head Jennifer Duck Exits Amid Pricing Pressure, Obesity Drug Battle We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
The Indian government has set a minimum import price (MIP) for certain key pharmaceutical inputs to combat aggressive undercutting and dumping from Chinese manufacturers. The government imposed the floor price restrictions on import of potassium clavulanate, and some intermediates used for the manufacturing of clavulanic acid and potassium clavulanate. Potassium clavulanate is used by the…
DoP Shortlists Patented, Unlaunched Drugs for Global Tender Exemption, See Full List We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Sanofi India on Monday said it has appointed Deepak Arora as the company’s new Managing Director. In this role, he will define and drive the strategic vision for India in alignment with Sanofi’s global strategy, the company said in a statement. Arora will also spearhead strategic priorities to accelerate innovation and agility throughout the organisation,…
The first child to receive a new experimental gene therapy for a rare neurological disorder died a few days after dosing, the company sponsoring that trial said Wednesday. The company, Capsida Biotherapeutics, is one of a group of companies and labs engineering new viruses potentially capable of safely ferrying genes deep into the brain. Its…
Experts in the pharma industry and med-tech sectors hailed the GST reforms, noting that these will lower costs of medicines for patients, ease working capital constraints for businesses and strengthen India’s competitiveness globally.However, some of them also raised concerns about the wide gap between the new GST rates for medicines and raw materials, or active…
New Delhi: The pharmaceutical industry may get relief on the long-standing issue of Goods and Services Tax (GST) inversion, with recent discussions between companies and the government pointing to a favourable solution as part of GST reforms, people aware of the developments told ET.Several representatives from the pharmaceutical export industry recently met the GST Council…
New Delhi: The pharmaceutical and medtech industries are worried about the impending Goods and Services Tax (GST) reforms as they expect the step to impact operating costs and working capital, straining their financial health. Rajiv Nath, forum coordinator, The Association of Indian Medical Device Industry (AiMeD) said for equipment, electronics, reagents, and implants, reducing GST…